Laboratorios Grossman, S.A.

5 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• UNAPPROVED5 refused lines

  Unapproved new drug

  The product appeared to be a new drug within the meaning of section 201(p) of the FD&C Act without an approved New Drug Application. FDA can apply this charge to a food or supplement whose labeling presents it for drug uses.

• NO ENGLISH1 refused line

  Required label information not in English

  Information that must appear on the label appeared not to be given in English, or not to be repeated in every language used on the label.

Questions about Laboratorios Grossman, S.A.

Is Laboratorios Grossman, S.A. on an FDA import alert?

No listing for Laboratorios Grossman, S.A. appears in the FDA import alerts SupplierRadar checked on October 25, 2026. Country-wide alerts may still apply to its products; see the Mexico page.

Has FDA refused shipments from Laboratorios Grossman, S.A.?

Yes. FDA refused 5 shipment lines from Laboratorios Grossman, S.A. between June 17, 2019 and October 17, 2022. The most recent, on October 17, 2022, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as UNAPPROVED (unapproved new drug).

Why did FDA refuse Laboratorios Grossman, S.A.'s shipments?

The most frequent charges are UNAPPROVED (unapproved new drug, 5 lines) and NO ENGLISH (required label information not in english, 1 line).

What is Laboratorios Grossman, S.A.'s FEI number?

Laboratorios Grossman, S.A.'s FDA Establishment Identifier (FEI) is 3006330902.